Studies with cultured HCC cell lines, in vivo animal models, and human HCC samples indicated that H19 functions as an oncogene by regulating epigenetic modification, H19/miR-675 axis, miRNA sponge, drug resistance, and diverse signaling pathways. The gene discussed is H19; the disease is hepatocellular carcinoma.